Article
Mutation analysis of 419 family and prenatal diagnosis of 339 cases of spinal muscular atrophy in China.
BMC medical genetics - 18 Jun 2020
Sun Yingjie, Kong Xiangdong, Zhao Zhenhua, Zhao Xuechao
Abstract excerpt
BACKGROUND: Spinal muscular atrophy (SMA) is a common and lethal autosomal recessive neurodegenerative disease caused by mutations in the survival motor neuron 1 (SMN1) gene. At present, gene therapy medicine for SMA, i.e., Spinraza (Nusinersen), has been approved by the FDA, bringing hope to SMA patients and families. Accurate diagnosis is essential for treatment. Our goal was to detect genetic mutations in SMA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
